Where Tech Meets Bio
Latest News
Trogenix Ltd has launched its Odysseus platform, leveraging Synthetic Super-Enhancer (SSE) technology to advance precision viral immunotherapy for aggressive cancers.
Read More
Novartis Expands Radiopharmaceutical Portfolio with $745M Deal with Ratio Therapeutics
Novartis has struck a licensing agreement with Boston-based biotech Ratio Therapeutics, securing global rights to a promising cancer candidate targeting somatostatin receptor 2 (SSTR2). The …
Read More
Medable Adds Generative AI to Simplify and Speed Up Clinical Trials
Medable Inc. has introduced generative AI capabilities to its Medable Studio platform to streamline and accelerate digital and decentralized clinical trial workflows. The new feature, …
Read More
Latest News
40,000 NHS Healthcare Workers to Get AI Tool That Cuts Admin Time by 80%
Immunai and Teva Collaborate to Advance Clinical Trials in Oncology and Immunology
Enveda Advances AI-Discovered, Nature-Derived Drug ENV-294 to Phase 1 Trials
Genesis Therapeutics Collaborates with NVIDIA and Secures Additional NVentures Funding to Accelerate AI-Driven Drug Discovery
Recursion Unveils OpenPhenom-S/16: A Foundation Model for Microscopy Data
Schrödinger and Novartis Forge Partnership to Scale Computational Drug Discovery
Latest Insights
by Andrii Buvailo, PhD
This Company Anonymized 1.8 Trillion Records to Support Biomedical Research
In the rapidly evolving life sciences and healthcare landscape, the secure and privacy-preserving exchange and linkage of health data is paramount. The topic of biomedical …
Read More
by Andrii Buvailo, PhD
10 Notable Biotech Companies With Recent Major VC Rounds
As the biotech sector recovers to pre-COVID investment levels, venture capital firms have become more selective in their funding choices. In 2024, private U.S. drug …
Read More
Survey Highlights Critical Need for AI Adoption in Regulatory Affairs Amid Unsustainable Workloads
by Roman Kasianov
What will be the key trends in AI innovation in the Pharmaceutical Industry in 2025?
by Marina Hickson
Cautious Optimism in 2024 for Healthcare M&A
by Merlin Piscitelli
AI Is Key to Democratizing Drug Discovery
by Andrey Doronichev
Key Trends in Aging Research: Where Are We Now?
by Andrii Buvailo, PhD
Global Pharma R&D Investments Surpass $276 Billion Annually, Exceeding Previous Estimates
by Roman Kasianov
The Promise of Chatbots in Clinical Trials
by Illia Petrov
Even 10 Minutes Matter in Cancer Research
by Andrii Buvailo, PhD
From Our Partners
Sponsored by
Lantern Pharma
How AI Empowers Biomarker-Driven Clinical Trials
Sponsored by
MEDSIR
Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology
Sponsored by
Intelligencia AI
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Sponsored by
Trialize
Unlocking Interoperability with AI: How This Company is Building a New Framework for Clinical Trials
Partner Events
London Biotechnology Show 2025
Event Date: June 18, 2025 - June 19, 2025
Location: United Kingdom (Hall N7 & N8 Bett Global, Excel London, Royal Victoria Dock, 1 Western Gateway, London, UK, England, GB, E16 1XL)
Website: Link
Promo Code: 4CPHAK
Read more ›››
BIOCHINA 2025
Event Date: March 13, 2025 - March 15, 2025
Location: China (Suzhou International Expo Center)
Website: Link
Promo Code: biopharmatrend (valid till 2024-10-31)
Read more ›››
Global Clinical Trials Connect 2025
Promo Code: GCTC10 (valid till 2025-05-28)
Read more ›››
Case Studies
Sponsored by
Bioz
Bioz Badges — Advanced Data-Widgets for Confident E-commerce
Sponsored by
Biocompare
Biocompare: Offline Order Attribution Analysis Helps Demonstrate Marketing Effectiveness
Sponsored by
Lantern Pharma
Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®
Sponsored by
Kymera Therapeutics
Identifying High Impact Tissue Sparing E3 Ligases and Their Binders
Sponsored by
Trialize
Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days
Sponsored by
Celeris Therapeutics
Application of AI-driven Xanthos Platform for Designing Protein Degraders
Sponsored by
RECEPTOR.AI
AI Becomes a Drop-in Replacement for Docking
Sponsored by
RECEPTOR.AI
ArtiDock from Receptor.AI: Next-generation AI Docking That Beats DiffDock and AlphaFold-latest
Interviews
Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology
From Data to Treatment: Medidata's Fareed Melhem Discusses AI's Impact on Clinical Trials
The Synergistic Potential of AI and Synthetic Biology: Interview with S&P Global’s Miriam Fernández
[Interview] How D-Wave Brings Quantum Computing Into Biology
Most Read
Top 10 Companies Shaping the Brain-Computer Interface Landscape: Invasive vs Non-Invasive BCI Technology
The CRO Industry in Flux: Navigating Technology, Business Models, and Trends in Pharma R&D Outsourcing
AI Drug Discovery: Unleashing the Potential of Big Data and Machine Learning
Maturing Pharma 4.0: How Digital Transformation Continues To Reshape Pharmaceuticals